We are live on
!
Find out more
1CM
1492 Capital Management Portfolio holdings
AUM
$263M
1-Year Est. Return
61.9%
This Fund
S&P 500
This Quarter
Est. Return
-5.96%
1 Year Est. Return
+61.9%
3 Year Est. Return
+187.15%
5 Year Est. Return
+242.53%
10 Year Est. Return
+2,731.07%
AUM
$186M
AUM Growth
-$24.4M
(-12%)
Cap. Flow
-$3.49M
Cap. Flow
% of AUM
-1.88%
Top 10 Holdings %
Top 10 Hldgs %
30.51%
Holding
130
New
21
Increased
27
Reduced
49
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AIOT
PowerFleet Inc
AIOT
|
+$2.55M |
| 2 |
INR
Infinity Natural Resources
INR
|
+$2.54M |
| 3 |
Pegasystems
PEGA
|
+$2.06M |
| 4 |
ATI
ATI
|
+$1.48M |
| 5 |
Payoneer
PAYO
|
+$1.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$4.39M |
| 2 |
SharkNinja
SN
|
+$3.33M |
| 3 |
Carpenter Technology
CRS
|
+$3.28M |
| 4 |
Jefferies Financial Group
JEF
|
+$3.26M |
| 5 |
Golar LNG
GLNG
|
+$2.66M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.28% |
| 2 | Healthcare | 19.85% |
| 3 | Industrials | 17.31% |
| 4 | Financials | 13.8% |
| 5 | Communication Services | 8.19% |
Similar funds
KA
LCGC
DEA
EAN
PIP
VIG
SC
L
1492 Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, 1492 Capital Management held 130 positions worth $186M, down 12% from $210M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
1492 Capital Management's Q1 2025 filing shows 21 new, 27 increased, 49 reduced and 18 closed positions. Its largest new stake was PowerFleet Inc: 397,072 shares worth $2.18M. The largest sale was Intra-Cellular Therapies Inc., an estimated $4.39M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
- 1492 Capital Management's largest Q1 2025 buy was PowerFleet Inc: 397,072 shares worth $2.18M.
- 1492 Capital Management added most to Pegasystems in Q1 2025, an estimated $2.06M increase.
- 1492 Capital Management's biggest Q1 2025 reduction was SharkNinja, cutting an estimated $3.33M.
- 1492 Capital Management fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $4.39M.
- 1492 Capital Management's ten largest holdings make up 31% of its $186M portfolio in Q1 2025.
- 1492 Capital Management opened 21 new positions and closed 18 in Q1 2025.
- 1492 Capital Management's portfolio value fell 12% quarter-over-quarter to $186M.
Based on 1492 Capital Management's 13F filing for Q1 2025, filed 6 May 2025.